--- title: "MileCell Biotechnology 推出了新的公司網站，並任命林年偉博士為首席執行官，Wayne Vaz 為首席商務官" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/285959539.md" description: "MileCell 生物科技公司推出了重新設計的企業網站，旨在提升研究人員和行業合作伙伴的用户體驗。公司任命林念偉博士為首席執行官，韋恩·瓦茲為首席商務官。新網站具有改進的導航功能、擴展的科學內容以及技術資源中心。林博士將負責公司戰略和全球擴展，而瓦茲將專注於市場開發和技術商業化。MileCell 致力於支持基於細胞的檢測系統的需求，並通過各種國際認證保持高標準" datetime: "2026-05-11T14:14:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285959539.md) - [en](https://longbridge.com/en/news/285959539.md) - [zh-HK](https://longbridge.com/zh-HK/news/285959539.md) --- # MileCell Biotechnology 推出了新的公司網站，並任命林年偉博士為首席執行官，Wayne Vaz 為首席商務官 **MileCell Biotechnology Launches New Corporate Website, Appoints Nianwei Lin, PhD, as CEO and Wayne Vaz as CCO** MileCell Biotechnology (“MileCell”) today announced the launch of its newly redesigned website www.milecell-bio.com, delivering an enhanced digital experience for researchers and industry partners worldwide. The company also announced the appointments of Nianwei Lin, PhD, Chief Executive Officer and Wayne Vaz, Chief Commercial Officer. The new website was developed to improve usability, streamline product discovery, and provide researchers with easier access to technical resources supporting ADME, DMPK, toxicology, and cell therapy R&D applications. Key enhancements include intuitive navigation, expanded scientific content, improved global search, integrated quotation and shopping cart functionality, and a significantly expanded Resource Hub featuring publications, application notes, certificates of analysis (COAs), technical documentation, and quality system and compliance. “Our new website reflects MileCell’s commitment to providing a more efficient and informative user experience,” said Nianwei Lin, PhD, CEO of MileCell. “At the same time, we are strengthening our leadership team to drive the company’s next phase of global growth and customer engagement.” Dr. Lin brings extensive experience in biotechnology industry leadership and scientific innovation. As CEO, he will lead MileCell’s corporate strategy, operational execution, and global expansion initiatives. Wayne Vaz joins MileCell as Chief Commercial Officer driving corporate expansion, channel partner strategy and market development initiatives. Vaz brings deep expertise in commercializing technologies, products and services for life science industry research and bioproduction, corporate development and growth. “Our products and services are vital to supporting growing market demand for cell-based assay systems and new approach methodologies (NAMs) that replace or augment animal-based models,” said Vaz. The new website is now live and accessible to customers worldwide. **About MileCell Biotechnology** MileCell Biotechnology is a provider of high-quality biological products and research solutions supporting ADME, DMPK, toxicology, and cell therapy research. The company offers a broad portfolio of primary cells, subcellular fractions, biological matrices, media, reagents, and scientific support resources for pharmaceutical, biotechnology, and academic research customers. MileCell's operations are supported by internationally recognized management systems, including ISO 9001:2015 Quality Management, ISO 14001:2015 Environmental Management, ISO 45001:2018 Occupational Health & Safety Management and U.S-FDA Type II DMF. These certifications ensure that MileCell maintains high standards for product quality, environmental responsibility, and workplace safety. To learn more, please visit www.milecell-bio.com. Follow MileCell Biotechnology on LinkedIn, and YouTube. **Media Contact** Wayne Vaz Chief Commercial Officer wayne.vaz@milecell-bio.com View source version on businesswire.com: https://www.businesswire.com/news/home/20260511504370/en/ ### 相關股票 - [SANA.US](https://longbridge.com/zh-HK/quote/SANA.US.md) - [IBBQ.US](https://longbridge.com/zh-HK/quote/IBBQ.US.md) - [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md) - [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md) - [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md) ## 相關資訊與研究 - [摩根大通：生物科技板塊處於拐點，恢復覆蓋 14 家大型企業](https://longbridge.com/zh-HK/news/287112418.md) - [巨生醫獲 SelectUSA 醫療科技組金牌 啟動美國 A 輪募資目標 1000 萬美元](https://longbridge.com/zh-HK/news/286905054.md) - [新股 IPO 丨消息：丹諾醫藥超購 9026 倍](https://longbridge.com/zh-HK/news/286879275.md) - [鉅亨速報 - Factset 最新調查：Roivant Sciences LtdROIV-US 的目標價調升至 38 元，幅度約 8.57%](https://longbridge.com/zh-HK/news/287126179.md) - [【新股 IPO】生物科技公司丹諾醫藥-B(6872) 招股，一手入場費 3823.2 港元，抽唔抽？](https://longbridge.com/zh-HK/news/286354632.md)